reflecting the industry’s steadfast commitment to excellence and innovation. Several key factors underpin the robust growth forecast for the pharmaceutical analytical testing outsourcing market in ...

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

Can the U.S. pharmaceutical supply chain come home — or ... Dymowski expects even the larger entities to cast a fresh eye on production in North America, if not the U.S. For them to fully embrace a ...

Trump’s executive order will stifle pharmaceutical innovation, raise costs and endanger patients’ lives.

But the White House released an executive order Wednesday following Trump's speech that said pharmaceuticals would ... China and North America tariffs remain in place While drug companies have ...

There are many problems with the plan. For instance, it ignores the fact that generic drugs, which make up 90% of ...

President Donald Trump previewed on Tuesday evening that the pharmaceutical industry will be the next to face a "major" tariff. "We're going to tariff our pharmaceuticals. And once we do that ...

The partnership creates one of the largest global IV solutions manufacturing networks with combined production of an estimated 1.4 billion annual units and aims to bring additional supply chain ...

President Donald Trump is pledging to target the pharmaceutical ... be that the drug industry negotiates a favorable outcome by making various concessions,” Bank of America analysts wrote ...

When President Trump signed an executive order this month to try to reduce drug prices, the pharmaceutical industry scored a big win. Within 90 days, the order said, Trump’s staff should put ...

The U.S. pharmaceutical industry is bracing for a possible wave of tariffs on ... “We fully support strong policies and programs that incentivize the manufacture of medicines here in America," Crowley ...